{"gene":"CTSK","run_date":"2026-06-09T22:57:19","timeline":{"discoveries":[{"year":1997,"finding":"CTSK (cathepsin K) was mapped to chromosome 1q21, spans ~12.1 kb, contains eight exons and seven introns, and has a single transcriptional start site 49 bp upstream of the initiator Met codon; the 5' flanking region lacks canonical TATA and CAAT boxes, suggesting a non-canonical promoter mechanism for osteoclast-selective expression.","method":"Fluorescence in situ hybridization (FISH), PCR on genomic DNA, ribonuclease protection assay, 5' RACE, P1 genomic clone isolation","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal direct experimental methods (FISH, RACE, RPA) in a single focused study establishing genomic structure and transcription start site","pmids":["9143491"],"is_preprint":false},{"year":1999,"finding":"Loss-of-function mutations in CTSK (a premature stop codon K52X and a missense G79E) result in virtually absent cathepsin K protein in affected individuals and cause pycnodysostosis, an autosomal recessive osteosclerotic skeletal dysplasia; heterozygous carriers with 50-80% reduced protein levels show no phenotype, demonstrating that complete absence—not partial reduction—of cathepsin K is required for disease.","method":"DNA sequencing of CTSK gene, Western blot protein quantification in patient-derived cells","journal":"Journal of bone and mineral research","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal genotype-phenotype analysis with direct protein quantification by western blot, replicated across multiple pycnodysostosis studies","pmids":["10491211"],"is_preprint":false},{"year":1999,"finding":"The mouse cathepsin K gene (Ctsk) spans 10.1 kb with eight exons and seven introns, and is located approximately 4.5 kb downstream of the Arnt gene on mouse chromosome 3, with the genomic structure conserved between human and mouse.","method":"Genomic clone isolation, sequence analysis, chromosomal mapping","journal":"Matrix biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct genomic sequencing and chromosomal mapping, single lab but multiple orthogonal methods","pmids":["10372556"],"is_preprint":false},{"year":2005,"finding":"ARNT transcripts can read through the intergenic region and extend into CTSK as far as CTSK intron 3 (~3.7 kb downstream of the end of the longest previously described ARNT mRNA), potentially interfering with CTSK expression; novel CTSK transcripts with alternate 5' splicing and a cryptic upstream promoter were also identified.","method":"RT-PCR overlapping ARNT 3' end and CTSK 5' end, quantitative RT-PCR, EST sequence analysis","journal":"Comparative and functional genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct RT-PCR and quantitative RT-PCR across multiple tissues, single lab, two orthogonal methods","pmids":["18629217"],"is_preprint":false},{"year":2007,"finding":"Nine novel CTSK missense mutations cause pycnodysostosis; the L7P mutation within the predicted hydrophobic signal peptide domain significantly reduced cathepsin K protein expression in transfected COS-7 cells, indicating the mutation disrupts targeting and translocation of the nascent lysosomal protein across the ER membrane; all six novel missense mutations were predicted to cause incorrect protein folding based on 3D structural modeling.","method":"Western blot of COS-7 cells transfected with mutant CTSK, 3D structural modeling","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct transfection/Western blot functional assay with structural modeling, single lab","pmids":["17397052"],"is_preprint":false},{"year":2012,"finding":"Ctsk knockout (Ctsk-/-) mice show significantly delayed OA progression in a joint destabilization model, with reduced MMP-13 and ADAMTS-5 expression in chondrocytes and synovial cells, demonstrating that cathepsin K plays a direct role in early-to-intermediate osteoarthritis development, likely through regulating downstream matrix metalloproteinase expression.","method":"Ctsk-/- knockout mouse model, joint destabilization surgery, histomorphometry, immunohistochemistry for CTK/MMP-13/ADAMTS-5/TRAP","journal":"Arthritis and rheumatism","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO mouse with defined surgical OA model, multiple histological and protein expression readouts, replicated finding across multiple papers","pmids":["21968827"],"is_preprint":false},{"year":2015,"finding":"The CTSK missense mutation Y283C does not affect mRNA or protein levels of overexpressed CTSK in COS-7 cells but significantly reduces CTSK enzyme activity; 3D structural modeling indicates loss of the hydroxybenzene residue disrupts the hydrogen network and affects self-cleavage of the enzyme. These mutations cause thickened and softened cementum with cementocyte accumulation and disorganized alveolar bone structure in affected patients.","method":"COS-7 transfection, CTSK enzyme activity assay, RT-PCR, western blot, 3D structure modeling, histological staining (H&E, toluidine blue), atomic force microscopy, micro-CT","journal":"Journal of dental research","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct enzyme activity assay combined with structural modeling and multiple orthogonal methods in patient tissue and cell system","pmids":["25731711"],"is_preprint":false},{"year":2018,"finding":"Ctsk-/- mice undergoing destabilization of the medial meniscus (DMM) show delayed subchondral and calcified cartilage remodeling by osteoclasts and chondroclasts; Ctsk-/- mice have fewer growth plate-derived chondroclasts than WT during OA, suggesting cathepsin K differentially regulates chondroclastogenesis. PCR arrays of laser-captured osteoclasts identified differential expression of Atp6v0d2, Tnfrsf11a, Ca2, Calcr, Ccr1, Gpr68, Itgb3, Nfatc1, and Syk between WT and Ctsk-/- mice.","method":"Ctsk-/- knockout mouse model, DMM surgery, histomorphometry, TRAP staining, laser capture microdissection followed by targeted PCR arrays","journal":"Journal of cellular physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO mouse model, defined surgical phenotype, laser capture microdissection with targeted gene expression arrays, multiple orthogonal readouts","pmids":["29781506"],"is_preprint":false},{"year":2019,"finding":"Ctsk inhibition by adeno-associated virus (AAV) knockdown reduces TLR9 signaling, autophagy proteins (TFEB and LC3), and inflammatory cytokines in a periodontitis-with-RA mouse model; in vitro, Ctsk inhibition suppresses TLR9 downstream signaling and autophagy-related proteins in macrophages stimulated by CpG ODN (TLR9 agonist), placing Ctsk upstream of TLR9-mediated autophagy.","method":"AAV-mediated CTSK knockdown in vivo, siRNA knockdown in macrophages, micro-CT, IHC, western blot, qRT-PCR, immunofluorescence","journal":"Cell proliferation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo and in vitro knockdown with multiple readouts, single lab, results replicated in both systems","pmids":["31737959"],"is_preprint":false},{"year":2019,"finding":"Inhibition of Ctsk with BML-244 reduces TLR4 and TLR9 expression in vivo and specifically suppresses cytokine production in response to TLR9 engagement in vitro in a periodontitis-RA comorbidity model, confirming Ctsk as a mediator of TLR9 pathway signaling.","method":"Pharmacological Ctsk inhibition (BML-244) in DBA/1 mouse model, in vitro cytokine assays, bone erosion measurement","journal":"Journal of clinical periodontology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological inhibition with in vivo and in vitro validation, single lab, two orthogonal systems","pmids":["30636333"],"is_preprint":false},{"year":2020,"finding":"RUNX2 promotes osteoclast differentiation and bone resorption through the AKT/NFATc1/CTSK axis: wild-type RUNX2 increases mTORC2 activity, which specifically phosphorylates AKT at Ser473, promoting NFATc1 nuclear translocation and upregulating CTSK expression; AKT inhibition abrogates osteoclast formation, while constitutively activated AKT rescues differentiation impaired by mutant RUNX2.","method":"Stable RAW264.7 cell lines expressing WT or mutant RUNX2, F-actin ring formation assay, bone resorption assay, western blot for mTORC2/AKT/NFATc1/CTSK, AKT inhibition and constitutively active AKT rescue experiments","journal":"Calcified tissue international","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis established by pharmacological inhibition and genetic rescue experiments with multiple downstream readouts, placing CTSK downstream of RUNX2/AKT/NFATc1","pmids":["32008052"],"is_preprint":false},{"year":2022,"finding":"Loss of Trp53 and Rb1 in Ctsk-expressing cells drives osteosarcoma progression via elevated YAP expression and activity; YAP/TEAD1 complex binds the Glut1 promoter to upregulate glucose transporter 1 expression, increasing glucose metabolism; ablation of YAP signaling inhibited energy metabolism and delayed osteosarcoma progression in the Ctsk-Cre;Trp53f/f/Rb1f/f mouse model.","method":"Ctsk-Cre conditional knockout mouse model, ChIP/promoter binding assay (YAP/TEAD1 to Glut1 promoter), YAP ablation experiments, micro-CT, mechanistic Western blot","journal":"MedComm","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional mouse model with promoter binding assay and YAP ablation rescue, single lab","pmids":["35615117"],"is_preprint":false},{"year":2023,"finding":"Cathepsin K (CTSK)-positive periosteal stem cells (PSCs) in the orbital periosteum coexpress CD200 and colocalize with osteocalcin in the inner periosteal layer, demonstrate multipotent differentiation capacity, and are mobilized after orbital fracture; transcriptome sequencing revealed 3613 differentially expressed genes between CTSK+ PSCs and bone marrow MSCs, with PSCs showing enriched pathways for intramembranous osteogenesis.","method":"Immunofluorescence, immunohistochemistry, flow cytometry, transcriptome sequencing, multidirectional differentiation assays, GO analysis","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal characterization methods including transcriptomics and differentiation assays, single lab","pmids":["37639249"],"is_preprint":false},{"year":2023,"finding":"Sfrp4 is expressed in Ctsk-lineage periosteal stem cells (PSCs) and its deletion decreases the PSC pool, impairs clonal multipotency for osteoblast and chondrocyte differentiation, hampers periosteal response to bone injury, and abolishes PTH-dependent increases in PSC number and cortical bone formation; bulk RNA sequencing showed Sfrp4 deletion downregulates pathways for skeletal development and bone mineralization in Ctsk-lineage cells.","method":"Sfrp4 global deletion mouse model, flow cytometry for PSC quantification, clonal differentiation assays, bone organoid formation, periosteal injury model, PTH treatment, bulk RNA sequencing of Ctsk-lineage cells","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods including genetic deletion, functional assays, transcriptomics, and in vivo injury/PTH models in a single comprehensive study","pmids":["37931101"],"is_preprint":false},{"year":2024,"finding":"METTL3-mediated m6A modification of Ctsk mRNA regulates Ctsk+ calvarial stem cell (CSC) function; depletion of Mettl3 in Ctsk+ lineage cells delayed suture formation, decreased mineralization, impaired calvarial bone formation, and reduced Hedgehog (Hh) signaling; restoration of Hh signaling by genetic or pharmacological means partially rescued the abnormality, placing METTL3/m6A/Ctsk upstream of Hh signaling in CSCs.","method":"Ctsk-lineage-specific Mettl3 conditional knockout, MeRIP-seq, RNA-seq, micro-CT, histomorphometry, genetic and pharmacological Hh pathway rescue (Sufu crossing, SAG21 administration)","journal":"Journal of dental research","confidence":"High","confidence_rationale":"Tier 1 / Strong — MeRIP-seq identifying m6A modification site, conditional KO with rescue experiments, multiple orthogonal methods in one rigorous study","pmids":["38752256"],"is_preprint":false},{"year":2024,"finding":"T-2 toxin induces cartilage extracellular matrix degradation via METTL3-mediated m6A methylation of Ctsk mRNA; silencing METTL3 increases Ctsk expression and worsens ECM degradation, while increasing m6A methylation via dietary methionine supplementation mitigates cartilage damage; silencing Ctsk itself also aggravated HT-2 toxin-induced ECM degradation, defining the METTL3/m6A/Ctsk axis in cartilage homeostasis.","method":"MeRIP sequencing, RNA sequencing, siRNA knockdown of METTL3 and Ctsk, in vivo methionine supplementation, ECM degradation assays","journal":"International immunopharmacology","confidence":"High","confidence_rationale":"Tier 1 / Strong — MeRIP-seq identifies m6A modification of Ctsk, combined with genetic knockdown and in vivo rescue, multiple orthogonal methods","pmids":["39426235"],"is_preprint":false},{"year":2025,"finding":"Loss of CTSK in trabecular meshwork (TM) cells (siRNA knockdown) significantly disrupts collagen biogenesis and ECM homeostasis, increases intracellular calcium levels, and activates PRKD1, which enhances actin polymerization through the LIMK1/SSH1/cofilin pathway and promotes focal adhesion maturation; RhoQ and myosin motor proteins are significantly downregulated, indicating altered mechanotransduction.","method":"siRNA-mediated CTSK knockdown in human TM cells, unbiased proteomics, calcium level measurement, pathway analysis","journal":"bioRxiv (preprint)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with unbiased proteomics and functional readouts, single lab, preprint not yet peer-reviewed","pmids":["bio_10.1101_2025.02.10.637394"],"is_preprint":true},{"year":2025,"finding":"Ctsk+ osteoclasts regulate condylar morphogenesis through HIF-1α-dependent lysosomal biogenesis via the TSC2-mTORC1-TFEB axis; conditional knockout of HIF-1α in Ctsk+ cells causes disorganized ruffled borders and defective lysosomal biogenesis in osteoclasts, leading to cartilage accumulation at early timepoints and paradoxical cartilage reduction with accelerated subchondral mineralization at later timepoints.","method":"DTR transgenic mouse ablation of Ctsk+ cells, HIF-1α conditional knockout in Ctsk+ cells (HIF-1α∆ctsk-cre), histomorphometry, immunohistochemistry, electron microscopy of ruffled borders and lysosomes, mechanistic pathway analysis","journal":"Journal of dental research","confidence":"High","confidence_rationale":"Tier 2 / Strong — two complementary genetic mouse models (ablation + conditional KO) with ultrastructural (EM) and pathway validation, multiple orthogonal readouts","pmids":["41108121"],"is_preprint":false},{"year":2025,"finding":"Mycl, a MYC family transcription factor activated downstream of Sgk1-phosphorylated Stat3 (at Tyr705), directly binds the Ctsk promoter to regulate its transcription during osteoclastogenesis; Mycl overexpression rescues osteoclast differentiation impaired by Sgk1 inhibition, defining the Sgk1-Stat3-Mycl-Ctsk signaling axis.","method":"Sgk1 inhibitor (GSK650394) treatment, Stat3 phosphorylation western blot, Mycl overexpression rescue experiments, ChIP/promoter binding assay (Mycl to Ctsk promoter), in vivo micro-CT of trabecular bone mass","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct promoter binding assay combined with genetic rescue and pharmacological inhibition, defining a novel upstream regulatory axis","pmids":["41266497"],"is_preprint":false},{"year":2026,"finding":"Tucatinib directly binds and inhibits CTSK (confirmed by microscale thermophoresis, molecular docking, and CTSK activity assays) and also suppresses NFATc1-driven osteoclast differentiation by inhibiting DRP1 phosphorylation at Ser616, reducing mitochondrial ROS and stabilizing mitochondrial fission/fusion dynamics, thereby defining a dual DRP1/NFATc1/CTSK axis in osteoclastic bone resorption.","method":"Microscale thermophoresis (direct binding), molecular docking, CTSK enzymatic activity assay, DRP1 phosphorylation western blot, mtROS measurement, ovariectomized mouse model, bone marrow-derived monocyte/macrophage differentiation assays","journal":"Biochemical pharmacology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct binding confirmed by MST, enzymatic activity assay, and structural docking combined with mechanistic in vivo and in vitro studies","pmids":["41974330"],"is_preprint":false},{"year":2025,"finding":"Liquiritin upregulates CTSK expression in tumor-associated macrophages (TAMs), causing CXCL1 to colocalize with lysosomes and undergo accelerated lysosomal degradation; this CTSK-mediated lysosomal degradation of CXCL1 suppresses TAM-induced breast cancer neoangiogenesis in vitro and in vivo.","method":"LC-MS screening, CXCL1 ELISA, lysosome/CXCL1 colocalization imaging, CTSK expression analysis, CXCL1 overexpression rescue, zebrafish xenotransplantation, murine xenograft model","journal":"Phytomedicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — colocalization and overexpression rescue with in vivo validation, single lab, two orthogonal model systems","pmids":["41072283"],"is_preprint":false},{"year":2014,"finding":"CTSK selective inhibitor (CKSI) treatment in high-fat diet obese mice reduces adipose tissue weight gain, improves insulin sensitivity, and significantly downregulates PPARγ and C/EBPα expression—key transcription factors for adipogenic differentiation—demonstrating that CTSK promotes adipocyte differentiation through regulation of these transcription factors.","method":"Pharmacological CTSK inhibition in HFD-induced obese C57BL/6 mice, adipose tissue weight measurement, HOMA index, histological analysis of adipocyte size, western blot/qPCR for PPARγ and C/EBPα","journal":"Endocrine journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological inhibition with defined molecular readouts in vivo, single lab","pmids":["25410008"],"is_preprint":false}],"current_model":"CTSK encodes cathepsin K, a lysosomal cysteine protease of the papain superfamily that is abundantly expressed in osteoclasts and functions as the primary collagenase driving bone matrix degradation; its expression is transcriptionally controlled by the RUNX2/AKT/NFATc1 axis, the Sgk1/Stat3/Mycl axis, and METTL3-mediated m6A mRNA modification upstream of Hedgehog signaling, while at the protein level it is subject to regulation by HIF-1α-dependent lysosomal biogenesis (via TSC2/mTORC1/TFEB) in osteoclasts; complete loss of CTSK causes pycnodysostosis with absent bone resorption activity, and in non-skeletal contexts CTSK mediates TLR9-dependent inflammatory signaling, promotes adipocyte differentiation through PPARγ/C/EBPα, maintains ECM homeostasis and actin organization in trabecular meshwork cells via the PRKD1/LIMK1/cofilin pathway, and enables lysosomal degradation of CXCL1 in tumor-associated macrophages."},"narrative":{"mechanistic_narrative":"CTSK encodes cathepsin K, a lysosomal cysteine protease abundantly expressed in osteoclasts that serves as the principal effector of bone matrix degradation, and complete loss-of-function mutations cause the autosomal recessive osteosclerotic dysplasia pycnodysostosis—a phenotype requiring full protein absence rather than partial reduction [PMID:10491211]. Disease-causing missense substitutions act through distinct molecular routes: signal-peptide mutations (L7P) disrupt ER targeting and translocation of the nascent enzyme, while active-site-distorting mutations (Y283C) leave protein levels intact but abolish enzymatic activity by perturbing the hydrogen-bond network required for self-cleavage [PMID:17397052, PMID:25731711]. CTSK expression is driven by convergent transcriptional programs in osteoclastogenesis: the RUNX2/mTORC2/AKT(Ser473)/NFATc1 axis [PMID:32008052] and the Sgk1/Stat3(Tyr705)/Mycl axis, in which Mycl binds the Ctsk promoter directly [PMID:41266497], with METTL3-mediated m6A modification controlling Ctsk mRNA upstream of Hedgehog signaling in skeletal stem cells [PMID:38752256, PMID:39426235]. At the protein-functional level, osteoclast cathepsin K activity depends on HIF-1α-dependent lysosomal biogenesis through the TSC2/mTORC1/TFEB axis, which sustains ruffled-border integrity and matrix remodeling [PMID:41108121]. Beyond bone resorption, CTSK marks periosteal and calvarial skeletal stem-cell lineages with multipotent osteogenic capacity [PMID:37931101, PMID:38752256], promotes osteoarthritis progression by regulating MMP-13 and ADAMTS-5 expression [PMID:21968827], drives adipocyte differentiation via PPARγ and C/EBPα [PMID:25410008], mediates TLR9-dependent macrophage inflammatory signaling and autophagy [PMID:31737959, PMID:30636333], and enables lysosomal degradation of CXCL1 in tumor-associated macrophages [PMID:41072283]. Cathepsin K is a direct pharmacological target inhibited by tucatinib, which additionally suppresses NFATc1-driven osteoclast differentiation [PMID:41974330].","teleology":[{"year":1997,"claim":"Establishing the genomic architecture and transcription start site of CTSK was the prerequisite for understanding its osteoclast-selective expression, and revealed a non-canonical promoter lacking TATA/CAAT elements.","evidence":"FISH, 5' RACE, and ribonuclease protection mapping of the human gene to 1q21","pmids":["9143491"],"confidence":"High","gaps":["Did not identify the transcription factors driving osteoclast-selective expression","Promoter mechanism for tissue restriction left undefined"]},{"year":1999,"claim":"Reciprocal genotype-phenotype analysis answered whether CTSK is causally required for bone resorption, showing that complete—not partial—loss of cathepsin K causes pycnodysostosis.","evidence":"CTSK sequencing and patient-cell Western blot quantification across affected individuals and carriers","pmids":["10491211"],"confidence":"High","gaps":["Did not resolve how individual missense mutations impair function","Non-skeletal consequences of loss not addressed"]},{"year":1999,"claim":"Mapping the conserved mouse Ctsk locus immediately downstream of Arnt established the syntenic framework that later revealed transcriptional cross-talk between the two genes.","evidence":"Genomic clone isolation and chromosomal mapping in mouse","pmids":["10372556"],"confidence":"Medium","gaps":["No functional consequence of the Arnt-Ctsk proximity tested","Mouse-only structural description"]},{"year":2005,"claim":"RT-PCR across the ARNT-CTSK intergenic region showed ARNT read-through transcripts extending into CTSK and identified cryptic CTSK promoters, implying transcriptional interference from the neighboring locus.","evidence":"Overlapping RT-PCR, quantitative RT-PCR, and EST analysis across tissues","pmids":["18629217"],"confidence":"Medium","gaps":["Functional impact of read-through on CTSK output not quantified in osteoclasts","Physiological role of alternate transcripts unknown"]},{"year":2007,"claim":"Functional dissection of missense mutations distinguished defects in protein biogenesis from defects in catalysis, with signal-peptide mutations (L7P) impairing ER targeting and translocation.","evidence":"Transfection/Western blot of mutant CTSK in COS-7 cells plus 3D structural modeling","pmids":["17397052"],"confidence":"Medium","gaps":["Folding predictions not validated biochemically","Did not measure enzymatic activity of each variant"]},{"year":2015,"claim":"The Y283C variant resolved a separable class of mutation that preserves expression but ablates enzyme activity by disrupting the hydrogen network required for self-cleavage, linking catalytic loss to dental/cementum phenotypes.","evidence":"COS-7 enzyme activity assays, structural modeling, and patient-tissue histology/micro-CT","pmids":["25731711"],"confidence":"High","gaps":["Self-cleavage defect inferred from modeling rather than direct zymogen processing assay","Substrate-level consequences not profiled"]},{"year":2012,"claim":"Genetic ablation tested whether cathepsin K contributes to joint disease beyond bone, showing Ctsk-/- mice resist early osteoarthritis with reduced MMP-13 and ADAMTS-5.","evidence":"Ctsk-/- mice in a joint destabilization model with histomorphometry and immunohistochemistry","pmids":["21968827"],"confidence":"High","gaps":["Mechanism linking CTSK to MMP-13/ADAMTS-5 expression not defined","Direct versus indirect protease contribution unresolved"]},{"year":2018,"claim":"Cell-type-resolved analysis extended the OA role by showing CTSK differentially regulates chondroclastogenesis and subchondral remodeling, with altered osteoclast gene programs.","evidence":"Ctsk-/- DMM model with laser-capture microdissection and targeted PCR arrays of osteoclasts","pmids":["29781506"],"confidence":"High","gaps":["Causal drivers among the differentially expressed genes not isolated","Chondroclast versus osteoclast contributions not separated genetically"]},{"year":2020,"claim":"Epistasis experiments placed CTSK transcription downstream of a RUNX2/mTORC2/AKT(Ser473)/NFATc1 cascade, explaining how an osteogenic factor controls resorptive gene expression.","evidence":"RAW264.7 lines with WT/mutant RUNX2, AKT inhibition, constitutively active AKT rescue, and resorption assays","pmids":["32008052"],"confidence":"High","gaps":["Direct NFATc1 occupancy of the CTSK promoter not shown in this study","In vivo relevance of the axis not tested"]},{"year":2022,"claim":"Using Ctsk-Cre lineage tracing in a tumor model showed Ctsk-expressing cells can give rise to osteosarcoma via YAP/TEAD1-driven Glut1 upregulation and glucose metabolism.","evidence":"Ctsk-Cre;Trp53/Rb1 conditional knockout, ChIP/promoter binding, and YAP ablation","pmids":["35615117"],"confidence":"Medium","gaps":["Role of CTSK protease activity itself versus lineage identity not separated","Single conditional model"]},{"year":2023,"claim":"CTSK was established as a marker of multipotent periosteal/skeletal stem cells, reframing the gene as a lineage identifier beyond mature osteoclasts.","evidence":"Immunostaining, flow cytometry, transcriptomics, and differentiation assays of orbital periosteal CTSK+ cells; Sfrp4 deletion in Ctsk-lineage PSCs","pmids":["37639249","37931101"],"confidence":"High","gaps":["Functional requirement of CTSK protein in stem-cell behavior not directly tested","Relationship between CTSK+ stem cells and CTSK+ osteoclasts unresolved"]},{"year":2024,"claim":"MeRIP-seq defined post-transcriptional control of Ctsk by METTL3-mediated m6A modification, placing the METTL3/m6A/Ctsk axis upstream of Hedgehog signaling in skeletal stem cells and of ECM homeostasis in cartilage.","evidence":"Ctsk-lineage Mettl3 conditional knockout with Hh rescue, plus MeRIP-seq and siRNA in toxin-induced cartilage degradation","pmids":["38752256","39426235"],"confidence":"High","gaps":["The reader protein interpreting Ctsk m6A marks not identified","Whether m6A alters CTSK protein activity or only abundance unclear"]},{"year":2019,"claim":"Knockdown and pharmacological inhibition revealed a non-canonical inflammatory role, placing Ctsk upstream of TLR9-mediated autophagy and cytokine production in macrophages.","evidence":"AAV/siRNA knockdown and BML-244 inhibition in periodontitis-RA models with TLR9 agonist stimulation","pmids":["31737959","30636333"],"confidence":"Medium","gaps":["Molecular substrate connecting CTSK to TLR9 not identified","Single lab; protease-dependence of the effect not established"]},{"year":2025,"claim":"Two genetic mouse models showed osteoclast CTSK function depends on HIF-1α-driven lysosomal biogenesis via TSC2/mTORC1/TFEB, linking protein-level regulation to ruffled-border integrity and condylar morphogenesis.","evidence":"Ctsk+ cell ablation and HIF-1α conditional knockout with EM of ruffled borders/lysosomes and pathway analysis","pmids":["41108121"],"confidence":"High","gaps":["Direct measurement of CTSK activity in HIF-1α-null osteoclasts not reported","Mechanism of biphasic cartilage phenotype incompletely defined"]},{"year":2025,"claim":"A promoter-binding study defined the Sgk1-Stat3(Tyr705)-Mycl axis controlling Ctsk transcription, with Mycl directly occupying the Ctsk promoter, adding a second transcriptional input to osteoclastogenesis.","evidence":"Sgk1 inhibition, Stat3 phospho-Western, Mycl overexpression rescue, ChIP, and trabecular bone micro-CT","pmids":["41266497"],"confidence":"High","gaps":["Interplay with the RUNX2/NFATc1 axis not integrated","Mycl-binding site specificity not finely mapped"]},{"year":2025,"claim":"Proteomics of CTSK-depleted trabecular meshwork cells extended CTSK function to ECM/collagen homeostasis and actin organization via a calcium/PRKD1/LIMK1/SSH1/cofilin pathway.","evidence":"siRNA knockdown in human TM cells with unbiased proteomics, calcium measurement, and pathway analysis (preprint)","pmids":["bio_10.1101_2025.02.10.637394"],"confidence":"Medium","gaps":["Preprint, not yet peer-reviewed","Direct protease substrates driving the actin remodeling not identified"]},{"year":2025,"claim":"A drug-induced gain-of-function context showed CTSK can drive lysosomal degradation of the chemokine CXCL1 in tumor-associated macrophages, suppressing breast-cancer neoangiogenesis.","evidence":"Liquiritin treatment with CXCL1-lysosome colocalization, CXCL1 overexpression rescue, and zebrafish/murine xenografts","pmids":["41072283"],"confidence":"Medium","gaps":["Whether CXCL1 is a direct CTSK substrate not biochemically demonstrated","Single lab; physiological (non-drug) relevance unclear"]},{"year":2026,"claim":"Direct binding studies validated CTSK as a druggable target of tucatinib while revealing a parallel DRP1/NFATc1 mitochondrial mechanism in osteoclast inhibition.","evidence":"Microscale thermophoresis, molecular docking, CTSK activity assay, DRP1 phospho-Western, mtROS, and ovariectomized mouse model","pmids":["41974330"],"confidence":"High","gaps":["Relative contribution of direct CTSK inhibition versus DRP1/NFATc1 effect to bone outcome unquantified","Selectivity against other cathepsins not detailed"]},{"year":null,"claim":"It remains unresolved how the physiological substrate repertoire of cathepsin K beyond bone collagen (e.g., CXCL1, ECM components in TM and cartilage) is selected, and how its multiple transcriptional and post-transcriptional inputs are integrated across the osteoclast versus skeletal-stem-cell states.","evidence":"","pmids":[],"confidence":"Low","gaps":["Direct substrate identification for non-bone roles lacking","Integration of RUNX2/NFATc1, Sgk1/Mycl, and METTL3/m6A inputs not unified","Structural basis of substrate specificity not addressed in the corpus"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[6,16,19,20]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[6,19]}],"localization":[{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[17,20]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[5,15,16]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[13,14,17]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[8,9,20]}],"complexes":[],"partners":[],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P43235","full_name":"Cathepsin K","aliases":["Cathepsin O","Cathepsin O2","Cathepsin X"],"length_aa":329,"mass_kda":37.0,"function":"Thiol protease involved in osteoclastic bone resorption and may participate partially in the disorder of bone remodeling. Displays potent endoprotease activity against fibrinogen at acid pH. May play an important role in extracellular matrix degradation. Involved in the release of thyroid hormone thyroxine (T4) by limited proteolysis of TG/thyroglobulin in the thyroid follicle lumen (PubMed:11082042)","subcellular_location":"Lysosome; Secreted; Apical cell membrane","url":"https://www.uniprot.org/uniprotkb/P43235/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CTSK","classification":"Not Classified","n_dependent_lines":20,"n_total_lines":1208,"dependency_fraction":0.016556291390728478},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CTSK","total_profiled":1310},"omim":[{"mim_id":"607948","title":"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO","url":"https://www.omim.org/entry/607948"},{"mim_id":"605474","title":"TOLL-LIKE RECEPTOR 9; TLR9","url":"https://www.omim.org/entry/605474"},{"mim_id":"604312","title":"CYSTATIN 3; CST3","url":"https://www.omim.org/entry/604312"},{"mim_id":"604146","title":"SYNAPTOTAGMIN 7; SYT7","url":"https://www.omim.org/entry/604146"},{"mim_id":"601105","title":"CATHEPSIN K; CTSK","url":"https://www.omim.org/entry/601105"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Vesicles","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"cervix","ntpm":333.6}],"url":"https://www.proteinatlas.org/search/CTSK"},"hgnc":{"alias_symbol":["PKND"],"prev_symbol":["CTSO2","CTSO","PYCD"]},"alphafold":{"accession":"P43235","domains":[{"cath_id":"3.90.70.10","chopping":"84-329","consensus_level":"medium","plddt":96.8463,"start":84,"end":329}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P43235","model_url":"https://alphafold.ebi.ac.uk/files/AF-P43235-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P43235-F1-predicted_aligned_error_v6.png","plddt_mean":94.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CTSK","jax_strain_url":"https://www.jax.org/strain/search?query=CTSK"},"sequence":{"accession":"P43235","fasta_url":"https://rest.uniprot.org/uniprotkb/P43235.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P43235/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P43235"}},"corpus_meta":[{"pmid":"15987910","id":"PMC_15987910","title":"Mycobacterium tuberculosis serine/threonine kinases PknB, PknD, PknE, and PknF phosphorylate multiple FHA domains.","date":"2005","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/15987910","citation_count":70,"is_preprint":false},{"pmid":"36138018","id":"PMC_36138018","title":"Cathepsin K regulates the tumor growth and metastasis by IL-17/CTSK/EMT axis and mediates M2 macrophage polarization in castration-resistant prostate cancer.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/36138018","citation_count":68,"is_preprint":false},{"pmid":"22243650","id":"PMC_22243650","title":"Role of Mycobacterium tuberculosis pknD in the pathogenesis of central nervous system tuberculosis.","date":"2012","source":"BMC microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/22243650","citation_count":60,"is_preprint":false},{"pmid":"16879801","id":"PMC_16879801","title":"Mycobacterium tuberculosis transporter MmpL7 is a potential substrate for kinase PknD.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16879801","citation_count":57,"is_preprint":false},{"pmid":"17397052","id":"PMC_17397052","title":"Molecular analysis and characterization of nine novel CTSK mutations in twelve patients affected by pycnodysostosis. Mutation in brief #961. Online.","date":"2007","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/17397052","citation_count":54,"is_preprint":false},{"pmid":"15136047","id":"PMC_15136047","title":"Sensor domain of the Mycobacterium tuberculosis receptor Ser/Thr protein kinase, PknD, forms a highly symmetric beta propeller.","date":"2004","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15136047","citation_count":53,"is_preprint":false},{"pmid":"23434822","id":"PMC_23434822","title":"Caffeine enhances osteoclast differentiation and maturation through p38 MAP kinase/Mitf and DC-STAMP/CtsK and TRAP pathway.","date":"2013","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/23434822","citation_count":49,"is_preprint":false},{"pmid":"21968827","id":"PMC_21968827","title":"Osteoarthritic change is delayed in a Ctsk-knockout mouse model of osteoarthritis.","date":"2012","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/21968827","citation_count":47,"is_preprint":false},{"pmid":"17242402","id":"PMC_17242402","title":"Allosteric activation by dimerization of the PknD receptor Ser/Thr protein kinase from Mycobacterium tuberculosis.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17242402","citation_count":44,"is_preprint":false},{"pmid":"31737959","id":"PMC_31737959","title":"Inhibition of Ctsk modulates periodontitis with arthritis via downregulation of TLR9 and autophagy.","date":"2019","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/31737959","citation_count":42,"is_preprint":false},{"pmid":"10491211","id":"PMC_10491211","title":"Mutations of CTSK result in pycnodysostosis via a reduction in cathepsin K protein.","date":"1999","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/10491211","citation_count":41,"is_preprint":false},{"pmid":"9143491","id":"PMC_9143491","title":"Genomic organization and chromosome localization of the human cathepsin K gene (CTSK).","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9143491","citation_count":39,"is_preprint":false},{"pmid":"30636333","id":"PMC_30636333","title":"Inhibition of Ctsk alleviates periodontitis and comorbid rheumatoid arthritis via downregulation of the TLR9 signalling pathway.","date":"2019","source":"Journal of clinical periodontology","url":"https://pubmed.ncbi.nlm.nih.gov/30636333","citation_count":36,"is_preprint":false},{"pmid":"9613569","id":"PMC_9613569","title":"Cloning and characterisation of the pknD gene encoding an eukaryotic-type protein kinase in the cyanobacterium Anabaena sp. PCC7120.","date":"1998","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/9613569","citation_count":33,"is_preprint":false},{"pmid":"17766419","id":"PMC_17766419","title":"Chlamydophila pneumoniae PknD exhibits dual amino acid specificity and phosphorylates Cpn0712, a putative type III secretion YscD homolog.","date":"2007","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/17766419","citation_count":33,"is_preprint":false},{"pmid":"32008052","id":"PMC_32008052","title":"New Function of RUNX2 in Regulating Osteoclast Differentiation via the AKT/NFATc1/CTSK Axis.","date":"2020","source":"Calcified tissue international","url":"https://pubmed.ncbi.nlm.nih.gov/32008052","citation_count":31,"is_preprint":false},{"pmid":"30387921","id":"PMC_30387921","title":"LncRNA-Jak3:Jak3 coexpressed pattern regulates monosodium urate crystal-induced osteoclast differentiation through Nfatc1/Ctsk expression.","date":"2018","source":"Environmental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/30387921","citation_count":27,"is_preprint":false},{"pmid":"25731711","id":"PMC_25731711","title":"Dental Abnormalities Caused by Novel Compound Heterozygous CTSK Mutations.","date":"2015","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/25731711","citation_count":26,"is_preprint":false},{"pmid":"24269275","id":"PMC_24269275","title":"Exome sequencing identifies CTSK mutations in patients originally diagnosed as intermediate osteopetrosis.","date":"2013","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/24269275","citation_count":24,"is_preprint":false},{"pmid":"20933472","id":"PMC_20933472","title":"Effect of PstS sub-units or PknD deficiency on the survival of Mycobacterium tuberculosis.","date":"2010","source":"Tuberculosis (Edinburgh, Scotland)","url":"https://pubmed.ncbi.nlm.nih.gov/20933472","citation_count":22,"is_preprint":false},{"pmid":"10913696","id":"PMC_10913696","title":"The Mycobacterium bovis homologous protein of the Mycobacterium tuberculosis serine/threonine protein kinase Mbk (PknD) is truncated.","date":"2000","source":"FEMS microbiology letters","url":"https://pubmed.ncbi.nlm.nih.gov/10913696","citation_count":22,"is_preprint":false},{"pmid":"16739134","id":"PMC_16739134","title":"Characterization of the phosphorylation sites of Mycobacterium tuberculosis serine/threonine protein kinases, PknA, PknD, PknE, and PknH by mass spectrometry.","date":"2006","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/16739134","citation_count":20,"is_preprint":false},{"pmid":"19662513","id":"PMC_19662513","title":"A single nucleotide polymorphism in the porcine cathepsin K (CTSK) gene is associated with back fat thickness and production traits in Italian Duroc pigs.","date":"2009","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/19662513","citation_count":20,"is_preprint":false},{"pmid":"27558267","id":"PMC_27558267","title":"Molecular analysis of the CTSK gene in a cohort of 33 Brazilian families with pycnodysostosis from a cluster in a Brazilian Northeast region.","date":"2016","source":"European journal of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/27558267","citation_count":19,"is_preprint":false},{"pmid":"19674475","id":"PMC_19674475","title":"A mutation in CTSK gene in an autosomal recessive pycnodysostosis family of Pakistani origin.","date":"2009","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19674475","citation_count":18,"is_preprint":false},{"pmid":"29781506","id":"PMC_29781506","title":"Articular cartilage protection in Ctsk-/- mice is associated with cellular and molecular changes in subchondral bone and cartilage matrix.","date":"2018","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29781506","citation_count":18,"is_preprint":false},{"pmid":"39667460","id":"PMC_39667460","title":"Identification of core immune-related genes CTSK, C3, and IFITM1 for diagnosing Helicobacter pylori infection-associated gastric cancer through transcriptomic analysis.","date":"2024","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/39667460","citation_count":17,"is_preprint":false},{"pmid":"35615117","id":"PMC_35615117","title":"Deletion of Trp53 and Rb1 in Ctsk-expressing cells drives osteosarcoma progression by activating glucose metabolism and YAP signaling.","date":"2022","source":"MedComm","url":"https://pubmed.ncbi.nlm.nih.gov/35615117","citation_count":17,"is_preprint":false},{"pmid":"35456040","id":"PMC_35456040","title":"Verteporfin Inhibits the Progression of Spontaneous Osteosarcoma Caused by Trp53 and Rb1 Deficiency in Ctsk-Expressing Cells via Impeding Hippo Pathway.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35456040","citation_count":17,"is_preprint":false},{"pmid":"29796728","id":"PMC_29796728","title":"Genetic study of eight Egyptian patients with pycnodysostosis: identification of novel CTSK mutations and founder effect.","date":"2018","source":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA","url":"https://pubmed.ncbi.nlm.nih.gov/29796728","citation_count":17,"is_preprint":false},{"pmid":"23776655","id":"PMC_23776655","title":"Vaccination with recombinant Mycobacterium tuberculosis PknD attenuates bacterial dissemination to the brain in guinea pigs.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23776655","citation_count":16,"is_preprint":false},{"pmid":"19828035","id":"PMC_19828035","title":"A novel inhibitor of Chlamydophila pneumoniae protein kinase D (PknD) inhibits phosphorylation of CdsD and suppresses bacterial replication.","date":"2009","source":"BMC microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/19828035","citation_count":15,"is_preprint":false},{"pmid":"32117071","id":"PMC_32117071","title":"Associations of Serum Cathepsin K and Polymorphisms in CTSK Gene With Bone Mineral Density and Bone Metabolism Markers in Postmenopausal Chinese Women.","date":"2020","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/32117071","citation_count":15,"is_preprint":false},{"pmid":"25725806","id":"PMC_25725806","title":"A Mutation in CTSK Gene in an Autosomal Recessive Pycnodysostosis Family of Chinese Origin.","date":"2015","source":"Calcified tissue international","url":"https://pubmed.ncbi.nlm.nih.gov/25725806","citation_count":14,"is_preprint":false},{"pmid":"37931101","id":"PMC_37931101","title":"Sfrp4 is required to maintain Ctsk-lineage periosteal stem cell niche function.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/37931101","citation_count":12,"is_preprint":false},{"pmid":"20305575","id":"PMC_20305575","title":"A novel missense mutation in cathepsin K (CTSK) gene in a consanguineous Pakistani family with pycnodysostosis.","date":"2010","source":"Journal of investigative medicine : the official publication of the American Federation for Clinical Research","url":"https://pubmed.ncbi.nlm.nih.gov/20305575","citation_count":12,"is_preprint":false},{"pmid":"25410008","id":"PMC_25410008","title":"CTSK inhibitor exert its anti-obesity effects through regulating adipocyte differentiation in high-fat diet induced obese mice.","date":"2014","source":"Endocrine journal","url":"https://pubmed.ncbi.nlm.nih.gov/25410008","citation_count":12,"is_preprint":false},{"pmid":"21099701","id":"PMC_21099701","title":"Familial pycnodysostosis: identification of a novel mutation in the CTSK gene (cathepsin K).","date":"2011","source":"Journal of investigative medicine : the official publication of the American Federation for Clinical Research","url":"https://pubmed.ncbi.nlm.nih.gov/21099701","citation_count":11,"is_preprint":false},{"pmid":"32224503","id":"PMC_32224503","title":"Inverse relationship between autophagy and CTSK is related to bovine embryo quality.","date":"2020","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/32224503","citation_count":10,"is_preprint":false},{"pmid":"10372556","id":"PMC_10372556","title":"Complete genomic structure of the mouse cathepsin K gene (Ctsk) and its localization next to the Arnt gene on mouse chromosome 3.","date":"1999","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/10372556","citation_count":9,"is_preprint":false},{"pmid":"38752256","id":"PMC_38752256","title":"METTL3 Modulates Ctsk+ Lineage Supporting Cranial Osteogenesis via Hedgehog.","date":"2024","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/38752256","citation_count":8,"is_preprint":false},{"pmid":"24134756","id":"PMC_24134756","title":"Novel CTSK mutation resulting in an entire exon 2 skipping in a Thai girl with pycnodysostosis.","date":"2013","source":"Pediatrics international : official journal of the Japan Pediatric Society","url":"https://pubmed.ncbi.nlm.nih.gov/24134756","citation_count":8,"is_preprint":false},{"pmid":"33945887","id":"PMC_33945887","title":"Phenotypic and genotypic spectrum of CTSK variants in a cohort of twenty-five Indian patients with pycnodysostosis.","date":"2021","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33945887","citation_count":8,"is_preprint":false},{"pmid":"36245435","id":"PMC_36245435","title":"Altering osteoclast numbers using CTSK models in utero affects mice offspring craniofacial morphology.","date":"2022","source":"Orthodontics & craniofacial research","url":"https://pubmed.ncbi.nlm.nih.gov/36245435","citation_count":7,"is_preprint":false},{"pmid":"39426235","id":"PMC_39426235","title":"T-2 toxin induces chondrocyte extracellular matrix degradation by regulating the METTL3-mediated Ctsk m6A modification.","date":"2024","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39426235","citation_count":7,"is_preprint":false},{"pmid":"37930479","id":"PMC_37930479","title":"Prediction and therapeutic targeting of the tumor microenvironment-associated gene CTSK in gastric cancer.","date":"2023","source":"Discover oncology","url":"https://pubmed.ncbi.nlm.nih.gov/37930479","citation_count":6,"is_preprint":false},{"pmid":"39424989","id":"PMC_39424989","title":"IL-17RA/CTSK axis mediates H. pylori-induced castration-resistant prostate cancer growth.","date":"2024","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/39424989","citation_count":6,"is_preprint":false},{"pmid":"29441215","id":"PMC_29441215","title":"Pycnodysostosis: Novel Variants in CTSK and Occurrence of Giant Cell Tumor.","date":"2017","source":"Journal of pediatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29441215","citation_count":5,"is_preprint":false},{"pmid":"35315254","id":"PMC_35315254","title":"Clinical and genetic characterization of three Russian patients with pycnodysostosis due to pathogenic variants in the CTSK gene.","date":"2022","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35315254","citation_count":5,"is_preprint":false},{"pmid":"37639249","id":"PMC_37639249","title":"Discovery of CTSK+ Periosteal Stem Cells Mediating Bone Repair in Orbital Reconstruction.","date":"2023","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/37639249","citation_count":4,"is_preprint":false},{"pmid":"40315697","id":"PMC_40315697","title":"CTSK as a Collagen Degradation Marker Induces Gingival Recession During High-Force Orthodontic Tooth Movement.","date":"2025","source":"International dental journal","url":"https://pubmed.ncbi.nlm.nih.gov/40315697","citation_count":4,"is_preprint":false},{"pmid":"34143773","id":"PMC_34143773","title":"Phlpp1 is induced by estrogen in osteoclasts and its loss in Ctsk-expressing cells does not protect against ovariectomy-induced bone loss.","date":"2021","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/34143773","citation_count":4,"is_preprint":false},{"pmid":"39392433","id":"PMC_39392433","title":"Exosomes derived from mucoperiosteum Krt14+Ctsk+ cells promote bone regeneration by coupling enhanced osteogenesis and angiogenesis.","date":"2024","source":"Biomaterials science","url":"https://pubmed.ncbi.nlm.nih.gov/39392433","citation_count":3,"is_preprint":false},{"pmid":"38203479","id":"PMC_38203479","title":"Andrographolide Alleviates Oxidative Damage and Inhibits Apoptosis Induced by IHNV Infection via CTSK/BCL2/Cytc Axis.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38203479","citation_count":3,"is_preprint":false},{"pmid":"30967749","id":"PMC_30967749","title":"A Novel Variant c.847T>C in CTSK Gene Leading to Pycnodysostosis: A Case Report.","date":"2019","source":"Clinical medicine insights. Case reports","url":"https://pubmed.ncbi.nlm.nih.gov/30967749","citation_count":3,"is_preprint":false},{"pmid":"36752216","id":"PMC_36752216","title":"A SNP in the ovine cathepsin K (CTSK) gene is associated with yearling growth performance in a crossbred sheep population.","date":"2023","source":"Animal biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/36752216","citation_count":2,"is_preprint":false},{"pmid":"37255004","id":"PMC_37255004","title":"Unravelling the Relacatib activity against the CTSK proteins causing pycnodysostosis: a molecular docking and dynamics approach.","date":"2023","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/37255004","citation_count":2,"is_preprint":false},{"pmid":"41065357","id":"PMC_41065357","title":"Cathepsin K (CTSK) in Inflammatory and Immune-Mediated Diseases.","date":"2025","source":"Immunological investigations","url":"https://pubmed.ncbi.nlm.nih.gov/41065357","citation_count":1,"is_preprint":false},{"pmid":"41108121","id":"PMC_41108121","title":"Ctsk+ Osteoclasts Orchestrate Condylar Morphogenesis via Hypoxic Lysosome.","date":"2025","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/41108121","citation_count":1,"is_preprint":false},{"pmid":"37920752","id":"PMC_37920752","title":"Association Between CTSK Gene Polymorphisms and Response to Alendronate Treatment in Postmenopausal Chinese Women with Low Bone Mineral Density.","date":"2023","source":"Pharmacogenomics and personalized medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37920752","citation_count":1,"is_preprint":false},{"pmid":"40670571","id":"PMC_40670571","title":"Identification of CTSK as a TLR-related critical biomarker in liver cirrhosis via integrative bioinformatics and pathological characterization.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40670571","citation_count":1,"is_preprint":false},{"pmid":"41072283","id":"PMC_41072283","title":"Liquiritin in Aiduqing formula inhibits breast cancer neoangiogenesis by suppressing CTSK-mediated lysosomal degradation of CXCL1 in tumor-associated macrophages.","date":"2025","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41072283","citation_count":1,"is_preprint":false},{"pmid":"18629217","id":"PMC_18629217","title":"Atypical CTSK transcripts and ARNT transcription read-through into CTSK.","date":"2005","source":"Comparative and functional genomics","url":"https://pubmed.ncbi.nlm.nih.gov/18629217","citation_count":0,"is_preprint":false},{"pmid":"39684735","id":"PMC_39684735","title":"Case Report: A Novel Homozygous Variant of the CTSK Gene in Rare Pycnodysostosis.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39684735","citation_count":0,"is_preprint":false},{"pmid":"41266497","id":"PMC_41266497","title":"Mycl, activated by Sgk1-phosphorylated Stat3, mediates osteoclastogenesis via Ctsk transcriptional regulation.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41266497","citation_count":0,"is_preprint":false},{"pmid":"41974330","id":"PMC_41974330","title":"Tucatinib alleviates postmenopausal osteoporosis by suppressing osteoclast differentiation via regulating the DRP1/NFATc1/CTSK signaling pathway.","date":"2026","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41974330","citation_count":0,"is_preprint":false},{"pmid":"40792611","id":"PMC_40792611","title":"RANKL, OPG, and CTS-K Release in Bone Response to Immediate Nonfunctional Loading of a Single Implant in Mandibular Molar Sites During Osseointegration Establishment.","date":"2025","source":"Clinical and experimental dental research","url":"https://pubmed.ncbi.nlm.nih.gov/40792611","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.07.21.665966","title":"Wnt5a gain- and loss-of-function present distinctly in craniofacial bone","date":"2025-07-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.21.665966","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.02.10.637394","title":"Loss of Cathepsin K impairs collagen biogenesis and enhances actin polymerization in trabecular meshwork","date":"2025-02-11","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.10.637394","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.10.03.680228","title":"Zyxin Restricts Viral Fusion and Entry across Multiple Virus Families","date":"2025-10-03","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.03.680228","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.08.31.610656","title":"Osteogenic CpG Oligodeoxynucleotide, iSN40, Inhibits Osteo-clastogenesis in a TLR9-Dependent Manner","date":"2024-09-02","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.31.610656","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.02.616263","title":"Early intermittent low-dose sclerostin antibody treatment promotes surface bone formation and reduces bone loss, but also decreases osteocyte apoptosis and mechanotransduction in ovariectomized rats: a pilot study","date":"2024-10-02","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.02.616263","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":37493,"output_tokens":6149,"usd":0.102357,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15042,"output_tokens":5543,"usd":0.106893,"stage2_stop_reason":"end_turn"},"total_usd":0.20925,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"CTSK (cathepsin K) was mapped to chromosome 1q21, spans ~12.1 kb, contains eight exons and seven introns, and has a single transcriptional start site 49 bp upstream of the initiator Met codon; the 5' flanking region lacks canonical TATA and CAAT boxes, suggesting a non-canonical promoter mechanism for osteoclast-selective expression.\",\n      \"method\": \"Fluorescence in situ hybridization (FISH), PCR on genomic DNA, ribonuclease protection assay, 5' RACE, P1 genomic clone isolation\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal direct experimental methods (FISH, RACE, RPA) in a single focused study establishing genomic structure and transcription start site\",\n      \"pmids\": [\"9143491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Loss-of-function mutations in CTSK (a premature stop codon K52X and a missense G79E) result in virtually absent cathepsin K protein in affected individuals and cause pycnodysostosis, an autosomal recessive osteosclerotic skeletal dysplasia; heterozygous carriers with 50-80% reduced protein levels show no phenotype, demonstrating that complete absence—not partial reduction—of cathepsin K is required for disease.\",\n      \"method\": \"DNA sequencing of CTSK gene, Western blot protein quantification in patient-derived cells\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal genotype-phenotype analysis with direct protein quantification by western blot, replicated across multiple pycnodysostosis studies\",\n      \"pmids\": [\"10491211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The mouse cathepsin K gene (Ctsk) spans 10.1 kb with eight exons and seven introns, and is located approximately 4.5 kb downstream of the Arnt gene on mouse chromosome 3, with the genomic structure conserved between human and mouse.\",\n      \"method\": \"Genomic clone isolation, sequence analysis, chromosomal mapping\",\n      \"journal\": \"Matrix biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct genomic sequencing and chromosomal mapping, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"10372556\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ARNT transcripts can read through the intergenic region and extend into CTSK as far as CTSK intron 3 (~3.7 kb downstream of the end of the longest previously described ARNT mRNA), potentially interfering with CTSK expression; novel CTSK transcripts with alternate 5' splicing and a cryptic upstream promoter were also identified.\",\n      \"method\": \"RT-PCR overlapping ARNT 3' end and CTSK 5' end, quantitative RT-PCR, EST sequence analysis\",\n      \"journal\": \"Comparative and functional genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct RT-PCR and quantitative RT-PCR across multiple tissues, single lab, two orthogonal methods\",\n      \"pmids\": [\"18629217\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Nine novel CTSK missense mutations cause pycnodysostosis; the L7P mutation within the predicted hydrophobic signal peptide domain significantly reduced cathepsin K protein expression in transfected COS-7 cells, indicating the mutation disrupts targeting and translocation of the nascent lysosomal protein across the ER membrane; all six novel missense mutations were predicted to cause incorrect protein folding based on 3D structural modeling.\",\n      \"method\": \"Western blot of COS-7 cells transfected with mutant CTSK, 3D structural modeling\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct transfection/Western blot functional assay with structural modeling, single lab\",\n      \"pmids\": [\"17397052\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Ctsk knockout (Ctsk-/-) mice show significantly delayed OA progression in a joint destabilization model, with reduced MMP-13 and ADAMTS-5 expression in chondrocytes and synovial cells, demonstrating that cathepsin K plays a direct role in early-to-intermediate osteoarthritis development, likely through regulating downstream matrix metalloproteinase expression.\",\n      \"method\": \"Ctsk-/- knockout mouse model, joint destabilization surgery, histomorphometry, immunohistochemistry for CTK/MMP-13/ADAMTS-5/TRAP\",\n      \"journal\": \"Arthritis and rheumatism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO mouse with defined surgical OA model, multiple histological and protein expression readouts, replicated finding across multiple papers\",\n      \"pmids\": [\"21968827\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The CTSK missense mutation Y283C does not affect mRNA or protein levels of overexpressed CTSK in COS-7 cells but significantly reduces CTSK enzyme activity; 3D structural modeling indicates loss of the hydroxybenzene residue disrupts the hydrogen network and affects self-cleavage of the enzyme. These mutations cause thickened and softened cementum with cementocyte accumulation and disorganized alveolar bone structure in affected patients.\",\n      \"method\": \"COS-7 transfection, CTSK enzyme activity assay, RT-PCR, western blot, 3D structure modeling, histological staining (H&E, toluidine blue), atomic force microscopy, micro-CT\",\n      \"journal\": \"Journal of dental research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct enzyme activity assay combined with structural modeling and multiple orthogonal methods in patient tissue and cell system\",\n      \"pmids\": [\"25731711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Ctsk-/- mice undergoing destabilization of the medial meniscus (DMM) show delayed subchondral and calcified cartilage remodeling by osteoclasts and chondroclasts; Ctsk-/- mice have fewer growth plate-derived chondroclasts than WT during OA, suggesting cathepsin K differentially regulates chondroclastogenesis. PCR arrays of laser-captured osteoclasts identified differential expression of Atp6v0d2, Tnfrsf11a, Ca2, Calcr, Ccr1, Gpr68, Itgb3, Nfatc1, and Syk between WT and Ctsk-/- mice.\",\n      \"method\": \"Ctsk-/- knockout mouse model, DMM surgery, histomorphometry, TRAP staining, laser capture microdissection followed by targeted PCR arrays\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO mouse model, defined surgical phenotype, laser capture microdissection with targeted gene expression arrays, multiple orthogonal readouts\",\n      \"pmids\": [\"29781506\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Ctsk inhibition by adeno-associated virus (AAV) knockdown reduces TLR9 signaling, autophagy proteins (TFEB and LC3), and inflammatory cytokines in a periodontitis-with-RA mouse model; in vitro, Ctsk inhibition suppresses TLR9 downstream signaling and autophagy-related proteins in macrophages stimulated by CpG ODN (TLR9 agonist), placing Ctsk upstream of TLR9-mediated autophagy.\",\n      \"method\": \"AAV-mediated CTSK knockdown in vivo, siRNA knockdown in macrophages, micro-CT, IHC, western blot, qRT-PCR, immunofluorescence\",\n      \"journal\": \"Cell proliferation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo and in vitro knockdown with multiple readouts, single lab, results replicated in both systems\",\n      \"pmids\": [\"31737959\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Inhibition of Ctsk with BML-244 reduces TLR4 and TLR9 expression in vivo and specifically suppresses cytokine production in response to TLR9 engagement in vitro in a periodontitis-RA comorbidity model, confirming Ctsk as a mediator of TLR9 pathway signaling.\",\n      \"method\": \"Pharmacological Ctsk inhibition (BML-244) in DBA/1 mouse model, in vitro cytokine assays, bone erosion measurement\",\n      \"journal\": \"Journal of clinical periodontology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological inhibition with in vivo and in vitro validation, single lab, two orthogonal systems\",\n      \"pmids\": [\"30636333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"RUNX2 promotes osteoclast differentiation and bone resorption through the AKT/NFATc1/CTSK axis: wild-type RUNX2 increases mTORC2 activity, which specifically phosphorylates AKT at Ser473, promoting NFATc1 nuclear translocation and upregulating CTSK expression; AKT inhibition abrogates osteoclast formation, while constitutively activated AKT rescues differentiation impaired by mutant RUNX2.\",\n      \"method\": \"Stable RAW264.7 cell lines expressing WT or mutant RUNX2, F-actin ring formation assay, bone resorption assay, western blot for mTORC2/AKT/NFATc1/CTSK, AKT inhibition and constitutively active AKT rescue experiments\",\n      \"journal\": \"Calcified tissue international\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis established by pharmacological inhibition and genetic rescue experiments with multiple downstream readouts, placing CTSK downstream of RUNX2/AKT/NFATc1\",\n      \"pmids\": [\"32008052\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Loss of Trp53 and Rb1 in Ctsk-expressing cells drives osteosarcoma progression via elevated YAP expression and activity; YAP/TEAD1 complex binds the Glut1 promoter to upregulate glucose transporter 1 expression, increasing glucose metabolism; ablation of YAP signaling inhibited energy metabolism and delayed osteosarcoma progression in the Ctsk-Cre;Trp53f/f/Rb1f/f mouse model.\",\n      \"method\": \"Ctsk-Cre conditional knockout mouse model, ChIP/promoter binding assay (YAP/TEAD1 to Glut1 promoter), YAP ablation experiments, micro-CT, mechanistic Western blot\",\n      \"journal\": \"MedComm\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional mouse model with promoter binding assay and YAP ablation rescue, single lab\",\n      \"pmids\": [\"35615117\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Cathepsin K (CTSK)-positive periosteal stem cells (PSCs) in the orbital periosteum coexpress CD200 and colocalize with osteocalcin in the inner periosteal layer, demonstrate multipotent differentiation capacity, and are mobilized after orbital fracture; transcriptome sequencing revealed 3613 differentially expressed genes between CTSK+ PSCs and bone marrow MSCs, with PSCs showing enriched pathways for intramembranous osteogenesis.\",\n      \"method\": \"Immunofluorescence, immunohistochemistry, flow cytometry, transcriptome sequencing, multidirectional differentiation assays, GO analysis\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal characterization methods including transcriptomics and differentiation assays, single lab\",\n      \"pmids\": [\"37639249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Sfrp4 is expressed in Ctsk-lineage periosteal stem cells (PSCs) and its deletion decreases the PSC pool, impairs clonal multipotency for osteoblast and chondrocyte differentiation, hampers periosteal response to bone injury, and abolishes PTH-dependent increases in PSC number and cortical bone formation; bulk RNA sequencing showed Sfrp4 deletion downregulates pathways for skeletal development and bone mineralization in Ctsk-lineage cells.\",\n      \"method\": \"Sfrp4 global deletion mouse model, flow cytometry for PSC quantification, clonal differentiation assays, bone organoid formation, periosteal injury model, PTH treatment, bulk RNA sequencing of Ctsk-lineage cells\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods including genetic deletion, functional assays, transcriptomics, and in vivo injury/PTH models in a single comprehensive study\",\n      \"pmids\": [\"37931101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"METTL3-mediated m6A modification of Ctsk mRNA regulates Ctsk+ calvarial stem cell (CSC) function; depletion of Mettl3 in Ctsk+ lineage cells delayed suture formation, decreased mineralization, impaired calvarial bone formation, and reduced Hedgehog (Hh) signaling; restoration of Hh signaling by genetic or pharmacological means partially rescued the abnormality, placing METTL3/m6A/Ctsk upstream of Hh signaling in CSCs.\",\n      \"method\": \"Ctsk-lineage-specific Mettl3 conditional knockout, MeRIP-seq, RNA-seq, micro-CT, histomorphometry, genetic and pharmacological Hh pathway rescue (Sufu crossing, SAG21 administration)\",\n      \"journal\": \"Journal of dental research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — MeRIP-seq identifying m6A modification site, conditional KO with rescue experiments, multiple orthogonal methods in one rigorous study\",\n      \"pmids\": [\"38752256\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"T-2 toxin induces cartilage extracellular matrix degradation via METTL3-mediated m6A methylation of Ctsk mRNA; silencing METTL3 increases Ctsk expression and worsens ECM degradation, while increasing m6A methylation via dietary methionine supplementation mitigates cartilage damage; silencing Ctsk itself also aggravated HT-2 toxin-induced ECM degradation, defining the METTL3/m6A/Ctsk axis in cartilage homeostasis.\",\n      \"method\": \"MeRIP sequencing, RNA sequencing, siRNA knockdown of METTL3 and Ctsk, in vivo methionine supplementation, ECM degradation assays\",\n      \"journal\": \"International immunopharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — MeRIP-seq identifies m6A modification of Ctsk, combined with genetic knockdown and in vivo rescue, multiple orthogonal methods\",\n      \"pmids\": [\"39426235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Loss of CTSK in trabecular meshwork (TM) cells (siRNA knockdown) significantly disrupts collagen biogenesis and ECM homeostasis, increases intracellular calcium levels, and activates PRKD1, which enhances actin polymerization through the LIMK1/SSH1/cofilin pathway and promotes focal adhesion maturation; RhoQ and myosin motor proteins are significantly downregulated, indicating altered mechanotransduction.\",\n      \"method\": \"siRNA-mediated CTSK knockdown in human TM cells, unbiased proteomics, calcium level measurement, pathway analysis\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with unbiased proteomics and functional readouts, single lab, preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.02.10.637394\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Ctsk+ osteoclasts regulate condylar morphogenesis through HIF-1α-dependent lysosomal biogenesis via the TSC2-mTORC1-TFEB axis; conditional knockout of HIF-1α in Ctsk+ cells causes disorganized ruffled borders and defective lysosomal biogenesis in osteoclasts, leading to cartilage accumulation at early timepoints and paradoxical cartilage reduction with accelerated subchondral mineralization at later timepoints.\",\n      \"method\": \"DTR transgenic mouse ablation of Ctsk+ cells, HIF-1α conditional knockout in Ctsk+ cells (HIF-1α∆ctsk-cre), histomorphometry, immunohistochemistry, electron microscopy of ruffled borders and lysosomes, mechanistic pathway analysis\",\n      \"journal\": \"Journal of dental research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two complementary genetic mouse models (ablation + conditional KO) with ultrastructural (EM) and pathway validation, multiple orthogonal readouts\",\n      \"pmids\": [\"41108121\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Mycl, a MYC family transcription factor activated downstream of Sgk1-phosphorylated Stat3 (at Tyr705), directly binds the Ctsk promoter to regulate its transcription during osteoclastogenesis; Mycl overexpression rescues osteoclast differentiation impaired by Sgk1 inhibition, defining the Sgk1-Stat3-Mycl-Ctsk signaling axis.\",\n      \"method\": \"Sgk1 inhibitor (GSK650394) treatment, Stat3 phosphorylation western blot, Mycl overexpression rescue experiments, ChIP/promoter binding assay (Mycl to Ctsk promoter), in vivo micro-CT of trabecular bone mass\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct promoter binding assay combined with genetic rescue and pharmacological inhibition, defining a novel upstream regulatory axis\",\n      \"pmids\": [\"41266497\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Tucatinib directly binds and inhibits CTSK (confirmed by microscale thermophoresis, molecular docking, and CTSK activity assays) and also suppresses NFATc1-driven osteoclast differentiation by inhibiting DRP1 phosphorylation at Ser616, reducing mitochondrial ROS and stabilizing mitochondrial fission/fusion dynamics, thereby defining a dual DRP1/NFATc1/CTSK axis in osteoclastic bone resorption.\",\n      \"method\": \"Microscale thermophoresis (direct binding), molecular docking, CTSK enzymatic activity assay, DRP1 phosphorylation western blot, mtROS measurement, ovariectomized mouse model, bone marrow-derived monocyte/macrophage differentiation assays\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct binding confirmed by MST, enzymatic activity assay, and structural docking combined with mechanistic in vivo and in vitro studies\",\n      \"pmids\": [\"41974330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Liquiritin upregulates CTSK expression in tumor-associated macrophages (TAMs), causing CXCL1 to colocalize with lysosomes and undergo accelerated lysosomal degradation; this CTSK-mediated lysosomal degradation of CXCL1 suppresses TAM-induced breast cancer neoangiogenesis in vitro and in vivo.\",\n      \"method\": \"LC-MS screening, CXCL1 ELISA, lysosome/CXCL1 colocalization imaging, CTSK expression analysis, CXCL1 overexpression rescue, zebrafish xenotransplantation, murine xenograft model\",\n      \"journal\": \"Phytomedicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — colocalization and overexpression rescue with in vivo validation, single lab, two orthogonal model systems\",\n      \"pmids\": [\"41072283\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CTSK selective inhibitor (CKSI) treatment in high-fat diet obese mice reduces adipose tissue weight gain, improves insulin sensitivity, and significantly downregulates PPARγ and C/EBPα expression—key transcription factors for adipogenic differentiation—demonstrating that CTSK promotes adipocyte differentiation through regulation of these transcription factors.\",\n      \"method\": \"Pharmacological CTSK inhibition in HFD-induced obese C57BL/6 mice, adipose tissue weight measurement, HOMA index, histological analysis of adipocyte size, western blot/qPCR for PPARγ and C/EBPα\",\n      \"journal\": \"Endocrine journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological inhibition with defined molecular readouts in vivo, single lab\",\n      \"pmids\": [\"25410008\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CTSK encodes cathepsin K, a lysosomal cysteine protease of the papain superfamily that is abundantly expressed in osteoclasts and functions as the primary collagenase driving bone matrix degradation; its expression is transcriptionally controlled by the RUNX2/AKT/NFATc1 axis, the Sgk1/Stat3/Mycl axis, and METTL3-mediated m6A mRNA modification upstream of Hedgehog signaling, while at the protein level it is subject to regulation by HIF-1α-dependent lysosomal biogenesis (via TSC2/mTORC1/TFEB) in osteoclasts; complete loss of CTSK causes pycnodysostosis with absent bone resorption activity, and in non-skeletal contexts CTSK mediates TLR9-dependent inflammatory signaling, promotes adipocyte differentiation through PPARγ/C/EBPα, maintains ECM homeostasis and actin organization in trabecular meshwork cells via the PRKD1/LIMK1/cofilin pathway, and enables lysosomal degradation of CXCL1 in tumor-associated macrophages.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CTSK encodes cathepsin K, a lysosomal cysteine protease abundantly expressed in osteoclasts that serves as the principal effector of bone matrix degradation, and complete loss-of-function mutations cause the autosomal recessive osteosclerotic dysplasia pycnodysostosis—a phenotype requiring full protein absence rather than partial reduction [#1]. Disease-causing missense substitutions act through distinct molecular routes: signal-peptide mutations (L7P) disrupt ER targeting and translocation of the nascent enzyme, while active-site-distorting mutations (Y283C) leave protein levels intact but abolish enzymatic activity by perturbing the hydrogen-bond network required for self-cleavage [#4, #6]. CTSK expression is driven by convergent transcriptional programs in osteoclastogenesis: the RUNX2/mTORC2/AKT(Ser473)/NFATc1 axis [#10] and the Sgk1/Stat3(Tyr705)/Mycl axis, in which Mycl binds the Ctsk promoter directly [#18], with METTL3-mediated m6A modification controlling Ctsk mRNA upstream of Hedgehog signaling in skeletal stem cells [#14, #15]. At the protein-functional level, osteoclast cathepsin K activity depends on HIF-1α-dependent lysosomal biogenesis through the TSC2/mTORC1/TFEB axis, which sustains ruffled-border integrity and matrix remodeling [#17]. Beyond bone resorption, CTSK marks periosteal and calvarial skeletal stem-cell lineages with multipotent osteogenic capacity [#13, #14], promotes osteoarthritis progression by regulating MMP-13 and ADAMTS-5 expression [#5], drives adipocyte differentiation via PPARγ and C/EBPα [#21], mediates TLR9-dependent macrophage inflammatory signaling and autophagy [#8, #9], and enables lysosomal degradation of CXCL1 in tumor-associated macrophages [#20]. Cathepsin K is a direct pharmacological target inhibited by tucatinib, which additionally suppresses NFATc1-driven osteoclast differentiation [#19].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Establishing the genomic architecture and transcription start site of CTSK was the prerequisite for understanding its osteoclast-selective expression, and revealed a non-canonical promoter lacking TATA/CAAT elements.\",\n      \"evidence\": \"FISH, 5' RACE, and ribonuclease protection mapping of the human gene to 1q21\",\n      \"pmids\": [\"9143491\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the transcription factors driving osteoclast-selective expression\", \"Promoter mechanism for tissue restriction left undefined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Reciprocal genotype-phenotype analysis answered whether CTSK is causally required for bone resorption, showing that complete—not partial—loss of cathepsin K causes pycnodysostosis.\",\n      \"evidence\": \"CTSK sequencing and patient-cell Western blot quantification across affected individuals and carriers\",\n      \"pmids\": [\"10491211\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve how individual missense mutations impair function\", \"Non-skeletal consequences of loss not addressed\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Mapping the conserved mouse Ctsk locus immediately downstream of Arnt established the syntenic framework that later revealed transcriptional cross-talk between the two genes.\",\n      \"evidence\": \"Genomic clone isolation and chromosomal mapping in mouse\",\n      \"pmids\": [\"10372556\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional consequence of the Arnt-Ctsk proximity tested\", \"Mouse-only structural description\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"RT-PCR across the ARNT-CTSK intergenic region showed ARNT read-through transcripts extending into CTSK and identified cryptic CTSK promoters, implying transcriptional interference from the neighboring locus.\",\n      \"evidence\": \"Overlapping RT-PCR, quantitative RT-PCR, and EST analysis across tissues\",\n      \"pmids\": [\"18629217\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional impact of read-through on CTSK output not quantified in osteoclasts\", \"Physiological role of alternate transcripts unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Functional dissection of missense mutations distinguished defects in protein biogenesis from defects in catalysis, with signal-peptide mutations (L7P) impairing ER targeting and translocation.\",\n      \"evidence\": \"Transfection/Western blot of mutant CTSK in COS-7 cells plus 3D structural modeling\",\n      \"pmids\": [\"17397052\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Folding predictions not validated biochemically\", \"Did not measure enzymatic activity of each variant\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"The Y283C variant resolved a separable class of mutation that preserves expression but ablates enzyme activity by disrupting the hydrogen network required for self-cleavage, linking catalytic loss to dental/cementum phenotypes.\",\n      \"evidence\": \"COS-7 enzyme activity assays, structural modeling, and patient-tissue histology/micro-CT\",\n      \"pmids\": [\"25731711\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Self-cleavage defect inferred from modeling rather than direct zymogen processing assay\", \"Substrate-level consequences not profiled\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Genetic ablation tested whether cathepsin K contributes to joint disease beyond bone, showing Ctsk-/- mice resist early osteoarthritis with reduced MMP-13 and ADAMTS-5.\",\n      \"evidence\": \"Ctsk-/- mice in a joint destabilization model with histomorphometry and immunohistochemistry\",\n      \"pmids\": [\"21968827\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking CTSK to MMP-13/ADAMTS-5 expression not defined\", \"Direct versus indirect protease contribution unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Cell-type-resolved analysis extended the OA role by showing CTSK differentially regulates chondroclastogenesis and subchondral remodeling, with altered osteoclast gene programs.\",\n      \"evidence\": \"Ctsk-/- DMM model with laser-capture microdissection and targeted PCR arrays of osteoclasts\",\n      \"pmids\": [\"29781506\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Causal drivers among the differentially expressed genes not isolated\", \"Chondroclast versus osteoclast contributions not separated genetically\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Epistasis experiments placed CTSK transcription downstream of a RUNX2/mTORC2/AKT(Ser473)/NFATc1 cascade, explaining how an osteogenic factor controls resorptive gene expression.\",\n      \"evidence\": \"RAW264.7 lines with WT/mutant RUNX2, AKT inhibition, constitutively active AKT rescue, and resorption assays\",\n      \"pmids\": [\"32008052\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct NFATc1 occupancy of the CTSK promoter not shown in this study\", \"In vivo relevance of the axis not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Using Ctsk-Cre lineage tracing in a tumor model showed Ctsk-expressing cells can give rise to osteosarcoma via YAP/TEAD1-driven Glut1 upregulation and glucose metabolism.\",\n      \"evidence\": \"Ctsk-Cre;Trp53/Rb1 conditional knockout, ChIP/promoter binding, and YAP ablation\",\n      \"pmids\": [\"35615117\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Role of CTSK protease activity itself versus lineage identity not separated\", \"Single conditional model\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"CTSK was established as a marker of multipotent periosteal/skeletal stem cells, reframing the gene as a lineage identifier beyond mature osteoclasts.\",\n      \"evidence\": \"Immunostaining, flow cytometry, transcriptomics, and differentiation assays of orbital periosteal CTSK+ cells; Sfrp4 deletion in Ctsk-lineage PSCs\",\n      \"pmids\": [\"37639249\", \"37931101\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional requirement of CTSK protein in stem-cell behavior not directly tested\", \"Relationship between CTSK+ stem cells and CTSK+ osteoclasts unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"MeRIP-seq defined post-transcriptional control of Ctsk by METTL3-mediated m6A modification, placing the METTL3/m6A/Ctsk axis upstream of Hedgehog signaling in skeletal stem cells and of ECM homeostasis in cartilage.\",\n      \"evidence\": \"Ctsk-lineage Mettl3 conditional knockout with Hh rescue, plus MeRIP-seq and siRNA in toxin-induced cartilage degradation\",\n      \"pmids\": [\"38752256\", \"39426235\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The reader protein interpreting Ctsk m6A marks not identified\", \"Whether m6A alters CTSK protein activity or only abundance unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Knockdown and pharmacological inhibition revealed a non-canonical inflammatory role, placing Ctsk upstream of TLR9-mediated autophagy and cytokine production in macrophages.\",\n      \"evidence\": \"AAV/siRNA knockdown and BML-244 inhibition in periodontitis-RA models with TLR9 agonist stimulation\",\n      \"pmids\": [\"31737959\", \"30636333\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular substrate connecting CTSK to TLR9 not identified\", \"Single lab; protease-dependence of the effect not established\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Two genetic mouse models showed osteoclast CTSK function depends on HIF-1α-driven lysosomal biogenesis via TSC2/mTORC1/TFEB, linking protein-level regulation to ruffled-border integrity and condylar morphogenesis.\",\n      \"evidence\": \"Ctsk+ cell ablation and HIF-1α conditional knockout with EM of ruffled borders/lysosomes and pathway analysis\",\n      \"pmids\": [\"41108121\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct measurement of CTSK activity in HIF-1α-null osteoclasts not reported\", \"Mechanism of biphasic cartilage phenotype incompletely defined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"A promoter-binding study defined the Sgk1-Stat3(Tyr705)-Mycl axis controlling Ctsk transcription, with Mycl directly occupying the Ctsk promoter, adding a second transcriptional input to osteoclastogenesis.\",\n      \"evidence\": \"Sgk1 inhibition, Stat3 phospho-Western, Mycl overexpression rescue, ChIP, and trabecular bone micro-CT\",\n      \"pmids\": [\"41266497\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay with the RUNX2/NFATc1 axis not integrated\", \"Mycl-binding site specificity not finely mapped\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Proteomics of CTSK-depleted trabecular meshwork cells extended CTSK function to ECM/collagen homeostasis and actin organization via a calcium/PRKD1/LIMK1/SSH1/cofilin pathway.\",\n      \"evidence\": \"siRNA knockdown in human TM cells with unbiased proteomics, calcium measurement, and pathway analysis (preprint)\",\n      \"pmids\": [\"bio_10.1101_2025.02.10.637394\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, not yet peer-reviewed\", \"Direct protease substrates driving the actin remodeling not identified\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"A drug-induced gain-of-function context showed CTSK can drive lysosomal degradation of the chemokine CXCL1 in tumor-associated macrophages, suppressing breast-cancer neoangiogenesis.\",\n      \"evidence\": \"Liquiritin treatment with CXCL1-lysosome colocalization, CXCL1 overexpression rescue, and zebrafish/murine xenografts\",\n      \"pmids\": [\"41072283\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether CXCL1 is a direct CTSK substrate not biochemically demonstrated\", \"Single lab; physiological (non-drug) relevance unclear\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Direct binding studies validated CTSK as a druggable target of tucatinib while revealing a parallel DRP1/NFATc1 mitochondrial mechanism in osteoclast inhibition.\",\n      \"evidence\": \"Microscale thermophoresis, molecular docking, CTSK activity assay, DRP1 phospho-Western, mtROS, and ovariectomized mouse model\",\n      \"pmids\": [\"41974330\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of direct CTSK inhibition versus DRP1/NFATc1 effect to bone outcome unquantified\", \"Selectivity against other cathepsins not detailed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how the physiological substrate repertoire of cathepsin K beyond bone collagen (e.g., CXCL1, ECM components in TM and cartilage) is selected, and how its multiple transcriptional and post-transcriptional inputs are integrated across the osteoclast versus skeletal-stem-cell states.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Direct substrate identification for non-bone roles lacking\", \"Integration of RUNX2/NFATc1, Sgk1/Mycl, and METTL3/m6A inputs not unified\", \"Structural basis of substrate specificity not addressed in the corpus\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [6, 16, 19, 20]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [6, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [17, 20]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [5, 15, 16]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [13, 14, 17]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [8, 9, 20]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}